Vantive
Vantive is an independent vital organ therapy company spun off from Baxter in 2025 that develops dialysis devices, CRRT systems, the Sharesource remote patient management platform, and advanced services to serve kidney disease patients, dialysis providers, and ICU clinicians across 100+ countries.
- Company typePublic
- Founded2025
- HeadquartersDeerfield, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vantive does
Vantive Health LLC is an independent, publicly traded healthcare company headquartered in Deerfield, Illinois, that was spun off from Baxter International Inc. in February 2025 and carries forward a 70-year legacy in kidney care and vital organ support therapies. The company designs, manufactures, and distributes medical devices for renal replacement therapy (HomeChoice peritoneal dialysis cycler, PrisMax, Prismaflex, Phoenix, PrismaLung+) and advanced dialyzers (Theranova with proprietary MCO membrane technology for HDx therapy), alongside peritoneal dialysis solutions and related pharmaceuticals. Its core platform architecture combines therapy hardware with the Sharesource Connectivity Platform — a two-way remote patient management system that has supported over 100 million home dialysis treatments across 10+ years — and the broader Vantive CONNECT digital suite, which includes the MyPD patient app, PD Telecare proactive monitoring, EMR integration, Home Navigators support, and Vantive Pinpoint Delivery tracking.
Vantive generates revenue through multiple streams: hardware and consumable sales to healthcare providers and dialysis centers (dialyzers, PD solutions, cyclers, acute therapy machines), recurring revenue from digital and remote patient management platforms, professional services and training (including VR-based clinician education), and licensing/distribution arrangements such as the exclusive U.S./Canada distribution of Spectral Medical's PMX hemoadsorption therapy. Its go-to-market combines direct enterprise sales, regional commercial websites across North America, EMEA, Asia Pacific and Latin America, channel partnerships with major U.S. dialysis providers (U.S. Renal Care, Innovative Renal Care), and event-driven engagement at major nephrology and critical care congresses. Vantive serves two principal customer segments: patients with chronic kidney disease and end-stage renal disease (alongside their clinicians) and ICU/critical care settings requiring continuous renal replacement therapy and multi-organ support, with a stated mission to expand home dialysis penetration from the current ~11% global rate among dialysis patients.
Vantive firmographics
Firmographics- Name
- Vantive
- Legal name
- Vantive Health LLC
- Website
- https://vantive.com
- Company type
- Public
- Founded year
- 2025
- Operating status
- Operating
- Short description
- Vantive is an independent vital organ therapy company spun off from Baxter in 2025 that develops dialysis devices, CRRT systems, the Sharesource remote patient management platform, and advanced services to serve kidney disease patients, dialysis providers, and ICU clinicians across 100+ countries.
- Ownership category
- akta.pro rank
Vantive industry classification
Industry- Product category
- Renal Care & Vital Organ Therapy
- NAICS
- Ambulatory Health Care Services (621), Home Health Care Services (621610)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Home Health Care Services (8082), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)
- akta.pro secondary industries
- Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support) (HLALAFAC), Peritoneal Dialysis (PD) Systems & Supplies (HLAHAKAB), Home Dialysis Support & Training Providers (HLAFAEAG)
Keywords
Where Vantive is headquartered
LocationHeadquarters
- HQ city
- Deerfield
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Vantive business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales
Revenue model
- Medical Devices and Dialysis Equipment: Vantive designs, manufactures, and distributes medical devices including dialysis machines, dialyzers (Theranova), peritoneal dialysis cyclers, and acute care therapy systems (PrisMax, Prismaflex). Products are sold to healthcare providers, dialysis centers, and directly to patients for home use.
- Pharmaceuticals and Dialysis Solutions: Vantive manufactures and distributes pharmaceutical products and dialysis solutions essential for renal care including peritoneal dialysis solutions and related consumables.
- Digital Solutions and Remote Patient Management: Vantive provides digital health platforms (Sharesource, Vantive CONNECT) that enable remote patient monitoring and management, supporting healthcare providers with data-driven insights and proactive care coordination.
- Advanced Services and Education: Vantive offers advanced services including training programs, technical support, patient support services (PD Telecare), and educational resources for clinicians and patients.
- PMX Hemoadsorption Distribution (Spectral Medical): Vantive is the exclusive distributor of PMX (Polymyxin B Hemoadsorption) in the U.S. and Canada and has non-exclusive rights to distribute Endotoxin Activity Assay (EAA) globally. PMX is a therapeutic device for treating endotoxic septic shock.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels10 records
Vantive product offering
Product offeringCore offering
Vantive develops, manufactures, and distributes medical devices, pharmaceuticals, and digital health platforms used in kidney care and vital organ support. Its portfolio includes dialysis machines, dialyzers, peritoneal dialysis cyclers, CRRT systems, dialysis solutions, and the Sharesource/Vantive CONNECT remote patient management ecosystem. The company sells these therapies, digital solutions, and advanced services to healthcare providers, dialysis centers, hospitals, and ICU departments globally, and operates a fully-integrated home dialysis ecosystem (HomeAdvantage) for patients with chronic kidney disease and end-stage renal disease.
Product overview
Vantive is a vital organ therapy company offering an integrated portfolio of therapies, digital solutions, and advanced services for kidney care and organ support. The core therapy offerings include peritoneal dialysis (PD) systems (HomeChoice), continuous renal replacement therapy devices (PrisMax, Prismaflex, Phoenix), and advanced dialysis technologies (Theranova dialyzer enabling HDx therapy). The digital ecosystem is anchored by the Sharesource Connectivity Platform for remote patient management, powered by Vantive CONNECT suite, which integrates with EMR systems and includes patient-facing tools (MyPD app) and clinical support (PD Telecare Program). The company also offers patient resources including PD Empowers and Global Travel Club. HomeAdvantage represents the fully-integrated home therapy ecosystem combining these products and services.
Differentiator
Problem solved
Functional benefit
Products and services
- Sharesource Connectivity Platform
- PrisMax System
- Prismaflex System
- Phoenix Dialysis System
- HomeChoice
- Theranova Dialyzer
- PrismaLung+
- Vantive CONNECT
- HomeAdvantage
- MyPD
- PD Telecare Program
- Vantive Learning Services
- Vantive Pinpoint Delivery
- Home Navigators
- PMX Hemoadsorption
- Vantive CONNECT Success Model
Quantifiable outcome
- Sharesource use associated with 45% lower all-cause mortality and 69% lower hospitalization rates for home PD patients
- +5 more outcomes
Companies that use Vantive
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Vantive technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature8 records
Vantive partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered flagship, core and minor.
- U.S. Renal CareflagshipMulti-year strategic agreement to expand access to home dialysis, enhance patient experience, and strengthen support for care teams. U.S. Renal Care partners with nephrologists across 32 states caring for 37,000+ kidney disease patients. Partnership includes Sharesource platform, EMR integration, and PD Telecare services.
- Innovative Renal CareflagshipMulti-year strategic agreement focused on expanding access to home dialysis, enhancing the therapy experience, and empowering patients and care teams through home dialysis care. IRC operates 230+ dialysis programs across 28 U.S. states serving ~16,000 patients. Partnership includes Sharesource Connectivity Platform, EMR integration, and PD Telecare Program.
- Spectral MedicalcoreVantive is Spectral's exclusive distributor of PMX (Polymyxin B Hemoadsorption) in the U.S. and Canada and has non-exclusive rights to distribute EAA (Endotoxin Activity Assay) globally. PMX is a therapeutic device for treating endotoxic septic shock. Vantive supports Spectral's clinical trials including the Tigris trial and plans to commercialize both EAA and PMX upon FDA approval.
- bioMérieuxminorbioMérieux is developing the CCL14 biomarker for use in assessing risk of patients with moderate or severe AKI developing persistent severe AKI. Vantive is committed to advancing research and delivering solutions for personalized AKI management in collaboration with bioMérieux.
- GS1minorVantive endorses and strongly supports GS1 standards for healthcare to improve patient safety and drive increased efficiency and integrity in the supply chain. Industry-wide adoption of these standards is encouraged.
Scale indicators8 records
Recent moves9 records
Expansion highlights5 records
Vantive competitors and assessment
Company assessmentDirect peers
- Fresenius Medical Care: Fresenius Medical Care is the world's largest provider of dialysis products and services, manufacturing hemodialysis machines, dialyzers, and PD systems, and operating thousands of dialysis clinics. It directly competes with Vantive across dialysis equipment, supplies, and consumables.
- Outset Medical: Outset Medical designs the Tablo Hemodialysis System, an enterprise-grade dialysis console for use in hospitals, clinics, and homes. It is a direct competitor in the home dialysis segment where Vantive's HomeAdvantage and Sharesource also compete.
- B. Braun: B. Braun's Avitum division manufactures dialysis machines, dialyzers, and CRRT systems, and operates dialysis centers globally. It is a direct competitor in renal care equipment and supplies, overlapping with Vantive's PrisMax, Theranova, and PD portfolios.
- Quanta Dialysis Technologies: Quanta develops the SC+ portable hemodialysis system designed for flexible use across in-center, home, and acute settings. It is a direct competitor targeting the same home dialysis opportunity as Vantive's HomeAdvantage ecosystem.
- Nipro Corporation: Nipro manufactures dialysis equipment, dialyzers, and related consumables under its Renal Care business. It competes directly with Vantive in dialyzers and PD products globally.
- Asahi Kasei Medical: Asahi Kasei Medical is a leading manufacturer of dialysis membranes (e.g., Vitabran, Vitapheal) and therapeutic apheresis products. It is a direct competitor to Vantive in dialyzer technology and blood purification.
- Nikkiso: Nikkiso's Medical division produces dialysis machines, CRRT systems, and blood purification devices. Its product overlap with Vantive's PrisMax/Prismaflex acute therapies makes it a direct competitor in renal care equipment.
Broad incumbents
- DaVita: DaVita is one of the largest U.S. dialysis service providers, operating thousands of clinics and treating hundreds of thousands of patients. As a major purchaser of Vantive's equipment and supplies, it is an important channel partner and competitor influence in shaping dialysis standards.
- Baxter International: Baxter was Vantive's parent company until the February 2025 spinoff and continues to operate in adjacent hospital products, IV solutions, and Pumps. While no longer a direct renal care competitor, Baxter retains related portfolios and shared IP exposure.
Emerging players
- Spectral Medical: Spectral Medical is the developer of PMX (Polymyxin B Hemoadsorption) and the EAA biomarker, with Vantive as exclusive U.S./Canada distributor. Although primarily a partner, Spectral overlaps with Vantive in the endotoxic septic shock and blood purification space.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Vantive social profiles
Digital presenceVantive compliance and trust
Trust signalCompliance1 record
Vantive financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vantive leadership team
Management profileNumber of profiles
Profiles6 records
Vantive funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vantive M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vantive
What does Vantive do?
Vantive develops, manufactures, and distributes medical devices, pharmaceuticals, and digital health platforms used in kidney care and vital organ support. Its portfolio includes dialysis machines, dialyzers, peritoneal dialysis cyclers, CRRT systems, dialysis solutions, and the Sharesource/Vantive CONNECT remote patient management ecosystem. The company sells these therapies, digital solutions, and advanced services to healthcare providers, dialysis centers, hospitals, and ICU departments globally, and operates a fully-integrated home dialysis ecosystem (HomeAdvantage) for patients with chronic kidney disease and end-stage renal disease.
Is Vantive a public or private company?
Vantive is a public company. It is classified as public and is currently operating.
When was Vantive founded?
Vantive was founded in 2025.
Where is Vantive based?
Vantive is headquartered in Deerfield, United States, in the North America region.
How does Vantive make money?
Five revenue lines are on record. Medical Devices and Dialysis Equipment is the primary driver. The others are pharmaceuticals and Dialysis Solutions, digital Solutions and Remote Patient Management, advanced Services and Education and PMX Hemoadsorption Distribution (Spectral Medical).
Who are Vantive's main competitors?
Direct peers on record are Fresenius Medical Care, Outset Medical, B. Braun, Quanta Dialysis Technologies, Nipro Corporation, Asahi Kasei Medical and Nikkiso. Broad incumbents are DaVita and Baxter International. Spectral Medical is listed as an emerging player.
Does Vantive have an API?
No public API is recorded for Vantive.
What industry is Vantive in?
Vantive's product category is Renal Care & Vital Organ Therapy. Its primary akta.pro industry code is HLAHAKAG, Home Dialysis Equipment & Remote Monitoring, with a secondary code of HLALAFAC, Kidney & Dialysis Remote Care (CKD/ESRD monitoring, home dialysis support). Its NAICS code is 621 and its SIC code is 3841.